Key result
Transdermal glyceryl trinitrate showed significant treatment effects for 8 hours, but efficacy was lost by 24 hours due to rapid tolerance that was only partly reversed by intermittent therapy.
Why the study?
Does intermittent transdermal glyceryl trinitrate therapy prevent the rapid development of nitrate tolerance compared to continuous therapy?
RCT
double-blind
randomized
Does intermittent transdermal glyceryl trinitrate therapy prevent the rapid development of nitrate tolerance compared to continuous therapy?
Transdermal nitrate tolerance develops rapidly within 24 hours of continuous use, and while intermittent therapy with a nitrate-free interval partially restores efficacy, some attenuation remains.
Transdermal GTN should be limited to short-term use; this RCT confirms intermittent regimens only partly overcome tolerance.
The long-term efficacy of transdermal nitrate therapy, in particular the ability of a single patch to provide 24 h prophylaxis against angina, has been questioned. Two mechanisms have been suggested for this loss of effect: the development of pharmacological tolerance, and premature patch exhaustion. This study was designed to investigate this problem, and in particular to investigate the time course of treatment failure. It comprised a randomized, double-blind, cross-over comparison of transdermal glyceryl trinitrate and matching placebo transdermal patches. Significant treatment effects were demonstrated by several criteria for 8 h of continuous therapy, with some limited effect persisting for 15 h. Loss of effect began to develop very soon after treatment was initiated and progressed in a steady, linear fashion so that there was virtually no treatment effect after 24 h. In contrast, during intermittent therapy, treatment effects were maintained on the second day following a nitrate-free interval. Significant benefit was demonstrated for up to 32 h (i.e. 8 h of treatment on day 2). Both nitrate-free intervals (12 and 16 h) seemed to be equally effective in maintaining efficacy after 3 h of treatment on the second day, although this was still somewhat attenuated compared with day 1. These results confirm that loss of therapeutic efficacy of transdermal nitrate is due to the development of tolerance and not premature patch exhaustion. In contrast to previous studies, however, they suggest that tolerance can only partly be reversed by intermittent therapy and also that the onset of tolerance is so rapid that it is well established in less than a day's treatment.
No takes yet. Share an insight, caveat, or question.
James et al. (1991) conducted an RCT in angina. transdermal glyceryl trinitrate vs. matching placebo transdermal patches was evaluated. Transdermal glyceryl trinitrate showed significant treatment effects for 8 hours, but efficacy was lost by 24 hours due to rapid tolerance that was only partly reversed by intermittent therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: